Clinical Trials

NCT07208058 | RECRUITING | PHASE3
30 participants

A Phase III Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of Plonmarlimab in Subjects With Relapsed/Refractory Rheumatic and Immunologic Disease-associated Haemophagocytic Lymphohistiocytosis (Also Known as Macrophage Activation Syndrome [MAS])

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-20
Start Date:
2025-11-21
Completion:
2026-12-20
Conditions
  • Relapsed/Refractory Rheumatic and Immunologic Disease-associated Haemophagocytic Lymphohistiocytosis
Interventions
  • DRUG
No Results Yet
NCT07206186 | ACTIVE_NOT_RECRUITING | NA
100 participants

Effect of Music on Patient Comfort

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-20
Start Date:
2025-06-05
Completion:
2026-04-09
Conditions
  • Perioperative Anxiety
Interventions
  • OTHER
No Results Yet
NCT07205315 | RECRUITING | EARLY_PHASE1
28 participants

A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-20
Start Date:
2025-09-26
Completion:
2027-11-30
Conditions
  • B-cell Acute Lymphoblastic Leukemia (B-ALL)
  • Chronic Lymphocytic Leukemia (CLL)
  • B-cell Non-Hodgkin's Lymphoma (B-NHL)
  • Autoimmune Hemolytic Anemia (AIHA)
Interventions
  • BIOLOGICAL
No Results Yet
NCT07170462 | RECRUITING | EARLY_PHASE1
50 participants

Cranberry and Gut Health in Crohn's Disease

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-20
Start Date:
2025-10-29
Completion:
2026-08-15
Conditions
  • Crohn Disease (CD)
  • Crohn Disease
Interventions
  • DRUG
  • DIETARY_SUPPLEMENT
No Results Yet
NCT07142564 | NOT_YET_RECRUITING | EARLY_PHASE1
100 participants

Carrier Care: An Innovative Approach to Support Small Babies in the NICU

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-20
Start Date:
2026-09-01
Completion:
2027-12-31
Conditions
  • Group 1: Carrier Care (CC) Followed by Skin-to-Skin Care (SSC) Followed by Family Choice
  • Group 2: Skin-to-Skin Care (SSC) Followed by Carrier Care (CC) Followed by Family Choice
Interventions
  • OTHER
No Results Yet
NCT07098364 | RECRUITING | PHASE1/PHASE2
33 participants

ST-067 in Combination With CD19-Directed CAR T-Cell Therapy (Liso-cel) in Relapsed/Refractory Large B-Cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-20
Start Date:
2025-12-27
Completion:
2030-10-04
Conditions
  • Recurrent Diffuse Large B-Cell Lymphoma
  • Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • Recurrent Grade 3b Follicular Lymphoma
  • Recurrent High-Grade B-Cell Lymphoma
  • Recurrent Indolent B-Cell Non-Hodgkin Lymphoma
  • Recurrent Primary Mediastinal Large B-Cell Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • Refractory Grade 3b Follicular Lymphoma
  • Refractory High-Grade B-Cell Lymphoma
  • Refractory Indolent B-Cell Non-Hodgkin Lymphoma
  • Refractory Primary Mediastinal Large B-Cell Lymphoma
Interventions
  • PROCEDURE
  • BIOLOGICAL
No Results Yet
NCT07089641 | RECRUITING | PHASE1
50 participants

ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-20
Start Date:
2025-07-28
Completion:
2027-07-30
Conditions
  • Glioblastoma
  • Glioblastoma, IDH-Wildtype
  • Gliosarcoma
  • Recurrent Glioblastoma, IDH-Wildtype
  • Recurrent Gliosarcoma
  • Resectable Glioblastoma
Interventions
  • PROCEDURE
  • DRUG
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page